Qila.io & Mascot Spincontrol partner to bring transparency in clinical research

Qila.io & Mascot Spincontrol partner to bring transparency in clinical research

The collab will likely evolve further with blockchain tokenization solutions in clinical research.

Qila.io

Mumbai: Blockchain-as-a-service company Qila.io has partnered with global clinical research centre Mascot Spincontrol to bring about transparency in clinical research through blockchain.

The aim of the collaboration is to ensure that clinical trial data is secure, transparent and tamper-proof so that integrity of research outcomes is maintained.

The partnership will enhance transparency in clinical research, fortify data security, and instill greater confidence among stakeholders. This will help result in positive regulatory outcomes and effective healthcare solutions.

“The synergies between Mascot Spincontrol and Qila.io are significant. Mascot brings extensive expertise in conducting clinical research, understanding the intricacies of regulatory compliance, and maintaining the highest standards of data integrity. On the other hand, Qila.io offers innovative blockchain technology solutions, particularly in tokenization, which ensures the security and transparency of data. By combining Mascot's clinical research capabilities with Qila'sblockchain expertise, we create a powerful synergy that addresses critical industry challenges and drives innovation in healthcare research,” Qila founder Sid Ugrankar.

As part of this collaboration, Mascot Spincontrol and Qila.io have several joint projects and initiatives planned in the coming months. These include implementing blockchain tokenization solutions for clinical research data sharing, pilot programs to demonstrate the effectiveness of blockchain technology in improving data integrity and transparency, and exploring opportunities for further integration of blockchain solutions in healthcare research. These initiatives are aimed at delivering tangible results and demonstrating the value of our collaboration to the industry.

“Blockchain deployment will improve the transparency and integrity of clinical trial results.  The clinical data results would be irreversible and hence would build great faith in brands’ promise! We are proud to be one of the first companies in our industry to embrace this technology” Mascot Spincontrol MD and founder Dr Mohit Lalvani.

Mumbai-based Mascot Spincontrolis a clinical research centre formed through a joint venture between Mascot Universal and Spincontrol France. The research centre helps beauty care, derma care, personal care and home care brands deliver their promise by clinically testing and substantiating their claims. It has worked with brand such as Loreal Paris, Himalaya, Hindustan Unilever Limited, Mamaearth, Dabur, 82°E, St. Botanica, firstcry, Joy, emami, Sugar, purple, Nykaa.com, Glenmark, Sun Pharma, Marico, Plum, WOW, Dot and Key, and The Man company.

“Deployment of blockchain in Clinical trial business is an industry first.  With this, we remain at the forefront of innovation in cosmetics clinical trial business and serving the needs of our customers,” added Mascot’s CEO, Mumtaz Lalvani.

Unlike other collaborations, which may focus solely on technology or research, the partnership between Qila and Mascot Spincontrol aims to combine the best of both worlds. It integrates advanced blockchain solutions with established clinical research practices.

In the future, the companies envision this partnership to evolve and to encompass a broader range of initiatives. These new initiatives will include the development of new blockchain-based solutions, the expansion of market presence, and the continued advancement of industry standards for data integrity and transparency.

As technology evolves and regulatory frameworks adapt, the companies remain committed to staying at the forefront of innovation and driving positive change in healthcare research.